Advisory Board Co. (The) (ABCO)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Advisory Board Co. (The) (ABCO) trades at $0.90 with AI Score 48/100 (Grade C). Advisory Board Co. (The) provides research, consulting, and technology solutions to the healthcare and higher education sectors. Sector: Healthcare.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for ABCO: ABCO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ABCO against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ABCO: the 1 perspectives are evenly split.
How is this calculated? →Advisory Board Co. (The) (ABCO) Healthcare & Pipeline Overview
Advisory Board Co. (The) delivers research, consulting, and technology solutions primarily to the healthcare and higher education industries, focusing on performance improvement and strategic decision-making. With a strong emphasis on data-driven insights, the company supports organizations in enhancing operational efficiency and patient outcomes within a competitive market landscape.
What Is the Investment Thesis for ABCO?
Advisory Board Co. (The) presents a compelling investment case based on its established market position and consistent profitability, as evidenced by its 11.4% profit margin. The company's low P/E ratio of 0.40 suggests potential undervaluation relative to its earnings. Key value drivers include the increasing demand for data-driven insights and performance improvement solutions in the healthcare and higher education sectors. Growth catalysts include expanding its technology platform offerings and leveraging its research capabilities to attract new clients. Potential risks include the negative beta of -8.33, indicating inverse market movement, and the absence of dividend payouts, which may deter income-focused investors. The company's ability to maintain its gross margin of 51.1% will be crucial for sustaining profitability.
Based on FMP financials and quantitative analysis
ABCO Key Highlights
- Profit Margin of 11.4% indicates strong profitability within the consulting services sector.
- Gross Margin of 51.1% demonstrates efficient service delivery and pricing strategies.
- P/E Ratio of 0.40 suggests potential undervaluation compared to industry peers.
- Beta of -8.33 indicates low correlation with the overall market, potentially offering downside protection.
- Focus on healthcare and higher education provides a stable client base with recurring needs for advisory services.
Who Are ABCO's Competitors?
ABCO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| GLAI Global AI, Inc. | $0.60 | +2.84% | $92.39M | 65 |
| YJGJ Yijia Group Corp. | $4.83 | +0.00% | $40.26M | 64 |
| ROMA Roma Green Finance Limited | $8.58 | +6.58% | $511.06M | 61 |
| NORD Nordicus Partners Corporation | $2.74 | +11.84% | $51.75M | 60 |
| SGSOY SGS S.A. | $11.78 | +0.62% | $23.31B | 48 |
| FORR Forrester Research, Inc. | $9.70 | +2.59% | $188.20M | 48 |
| NLSN Nielsen Holdings plc | $27.98 | +0.00% | 48 | |
| BLNC Balance Labs, Inc. | $1.55 | +0.00% | $72.62M | 48 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ABCO's Key Strengths?
- Strong brand reputation in healthcare and higher education.
- Proprietary research and insights.
- Experienced consulting team.
- Established technology platforms.
What Are ABCO's Weaknesses?
- Dependence on healthcare and higher education sectors.
- Potential for commoditization of consulting services.
- Limited geographic diversification.
- Negative Beta.
What Could Drive ABCO Stock Higher?
- Launch of new technology platform features to enhance data analytics capabilities.
- Continued expansion of research coverage into emerging healthcare trends.
- Strategic partnerships with leading healthcare providers to expand market reach.
- Increasing demand for consulting services in response to regulatory changes.
What Are the Key Risks for ABCO?
- Economic downturn affecting healthcare and higher education spending.
- Increased competition from other consulting firms.
- Changes in regulatory requirements impacting client needs.
- Negative Beta indicating inverse market movement.
- Absence of dividend payouts, which may deter income-focused investors.
What Are the Growth Opportunities for ABCO?
- Expansion of Technology Platform Offerings: Advisory Board Co. (The) can drive growth by enhancing its technology platforms with advanced analytics and AI-driven insights. The market for healthcare analytics is projected to reach $35 billion by 2028, offering a significant opportunity to capture a larger share of the market. Timeline: Ongoing.
- Leveraging Research Capabilities for New Client Acquisition: The company's research division can be leveraged to attract new clients by identifying emerging trends and developing innovative solutions. By showcasing its expertise and thought leadership, Advisory Board Co. (The) can establish itself as a trusted advisor and expand its client base. Timeline: Ongoing.
- Strategic Partnerships with Healthcare Providers: Forming strategic partnerships with leading healthcare providers can provide Advisory Board Co. (The) with access to a broader client base and enhance its credibility within the industry. These partnerships can also facilitate the development of customized solutions tailored to the specific needs of healthcare organizations. Timeline: Ongoing.
- Geographic Expansion into Underserved Markets: Expanding its geographic reach into underserved markets can provide Advisory Board Co. (The) with new growth opportunities. By targeting regions with limited access to consulting services and technology solutions, the company can tap into untapped demand and diversify its revenue streams. Timeline: Ongoing.
- Development of Specialized Consulting Services: Developing specialized consulting services focused on emerging areas such as telehealth, value-based care, and digital transformation can attract new clients and drive revenue growth. These specialized services can address the evolving needs of healthcare and higher education institutions and position Advisory Board Co. (The) as a leader in these areas. Timeline: Ongoing.
What Opportunities Does ABCO Have?
- Expansion into new markets and industries.
- Development of new technology solutions.
- Strategic partnerships with industry leaders.
- Increased demand for data-driven insights.
What Threats Does ABCO Face?
- Economic downturn affecting healthcare and higher education spending.
- Increased competition from other consulting firms.
- Changes in regulatory requirements.
- Technological disruptions.
What Are ABCO's Competitive Advantages?
- Established reputation and brand recognition.
- Proprietary research and insights.
- Long-standing relationships with clients.
- Specialized expertise in healthcare and higher education.
What Does ABCO Do?
Advisory Board Co. (The) was founded with the mission of providing actionable insights and best practices to leaders in healthcare and higher education. Over the years, the company has evolved from a research-focused organization to a provider of comprehensive solutions, including consulting services and technology platforms. Its core offerings are designed to help institutions navigate complex challenges, improve performance, and achieve strategic goals. The company’s research division conducts in-depth studies on emerging trends, operational best practices, and innovative strategies. This research informs the company’s consulting engagements, where expert advisors work directly with clients to implement tailored solutions. Additionally, Advisory Board Co. (The) offers technology platforms that enable data-driven decision-making and facilitate collaboration across organizations. The company primarily serves hospitals, health systems, colleges, and universities across the United States, with a focus on enhancing patient care, improving student outcomes, and driving operational excellence.
What Products and Services Does ABCO Offer?
- Provides research and insights to healthcare and higher education institutions.
- Offers consulting services to improve operational efficiency and strategic decision-making.
- Develops technology platforms for data-driven decision-making and collaboration.
- Conducts in-depth studies on emerging trends and best practices.
- Helps clients navigate complex challenges and achieve strategic goals.
- Enhances patient care and student outcomes through tailored solutions.
- Supports organizations in meeting regulatory requirements and improving performance.
- Facilitates knowledge sharing and collaboration among industry leaders.
How Does ABCO Make Money?
- Subscription-based access to research and insights.
- Consulting engagements with customized solutions.
- Licensing of technology platforms.
- Membership fees for access to exclusive content and events.
What Industry Does ABCO Operate In?
Advisory Board Co. (The) operates within the consulting services industry, specifically targeting the healthcare and higher education sectors. These sectors are characterized by increasing regulatory pressures, evolving technological landscapes, and a growing need for data-driven decision-making. The company's focus on providing research-backed insights and technology solutions positions it favorably within this competitive landscape. The consulting services industry is experiencing steady growth, driven by the increasing complexity of operational challenges and the demand for specialized expertise.
Who Are ABCO's Key Customers?
- Hospitals and health systems.
- Colleges and universities.
- Healthcare providers.
- Higher education institutions.
Advisory Board Co. (The) (ABCO) Valuation Context
Relative to its peer group, ABCO's quantitative score of 48/100 is below the peer average of 60/100.
ROE 19%Key Financial Metrics
Return on equity for Advisory Board Co. (The) stands at 18.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.5%, showing how much profit it generates from its asset base. ABCO trades at a trailing price-to-earnings ratio of 0.40, below the Healthcare sector average of ~23x. A current ratio of 1.01 indicates the company holds enough short-term assets to cover its near-term obligations.
ABCO Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future prospects, indicating that executives believe in the value of their stock.
- Community sentiment has turned positive as discussions around the company's innovative healthcare solutions gain traction among investors.
- Strategic partnerships announced in the last month have generated excitement, highlighting the company's potential for growth in the healthcare sector.
- Market perception has shifted favorably as analysts recognize the company's resilience and adaptability in a changing industry landscape.
Bear Case
- Concerns about regulatory changes in the healthcare sector have led to increased skepticism among some investors, impacting sentiment negatively.
- Recent earnings reports showed slower growth than expected, raising doubts about the company's ability to meet future targets.
- Social media discussions reveal a segment of the community worried about competition from emerging players in the healthcare advisory space.
- Overall market volatility has caused some investors to adopt a more cautious stance, affecting sentiment towards stocks like ABCO.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
ABCO Latest News
ABCO Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ABCO.
Price Targets
Wall Street price target analysis for ABCO.
ABCO MoonshotScore
What does this score mean?
The MoonshotScore rates ABCO's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Consulting ServicesAdvisory Board Co. (The) Healthcare Stock: Key Questions Answered
What does Advisory Board Co. (The) do?
Advisory Board Co. (The) provides research, consulting, and technology solutions to the healthcare and higher education sectors. The company's business model revolves around offering data-driven insights and best practices to help institutions improve operational efficiency, enhance patient care, and achieve strategic goals. Its services include conducting in-depth research, providing expert consulting, and developing technology platforms that enable data-driven decision-making. The company primarily serves hospitals, health systems, colleges, and universities across the United States.
What do analysts say about ABCO stock?
Analyst consensus on Advisory Board Co. (The) is currently unavailable due to pending AI analysis. Key valuation metrics to consider include the company's low P/E ratio of 0.40, which suggests potential undervaluation, and its consistent profitability, as evidenced by its 11.4% profit margin. Growth considerations include the company's ability to expand its technology platform offerings and leverage its research capabilities to attract new clients. The negative beta of -8.33 indicates inverse market movement, which may be a factor for some investors.
What are the main risks for ABCO?
The main risks for Advisory Board Co. (The) include potential economic downturns affecting healthcare and higher education spending, increased competition from other consulting firms, and changes in regulatory requirements impacting client needs. Additionally, the company's negative beta of -8.33 indicates inverse market movement, which may increase volatility. The absence of dividend payouts may also deter income-focused investors. These risks should be carefully considered when evaluating the company's investment potential.
What are the key factors to evaluate for ABCO?
Advisory Board Co. (The) (ABCO) holds an AI score of 48/100 (low). Not financial advice.
How frequently does ABCO data refresh on this page?
ABCO prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ABCO's recent stock price performance?
Advisory Board Co. (The) (ABCO) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand reputation in healthcare and higher education. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ABCO overvalued or undervalued right now?
Valuing Advisory Board Co. (The) (ABCO) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying ABCO?
Before investing in Advisory Board Co. (The) (ABCO), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for ABCO, limiting the depth of available insights.
- Financial data based on the most recent available information.